
-
OpenAI signs multi-billion dollar chip deal with AMD
-
Salah under fire as Liverpool star loses his spark
-
Paris stocks drop as French PM resigns, Tokyo soars
-
ICC finds Sudan militia chief guilty of crimes against humanity
-
Zverev dumped out of Shanghai Masters by France's Rinderknech
-
One hiker dead, hundreds rescued after heavy snowfall in China
-
Hundreds stage fresh anti-government protests in Madagascar
-
Feminist icon Gisele Pelicot back in court as man appeals rape conviction
-
US government shutdown enters second week
-
Kasatkina ends WTA season early after hitting 'breaking point'
-
Paris stocks drop as French PM resigns
-
Death toll from Indonesia school collapse rises to 63
-
Medicine Nobel to trio who identified immune system's 'security guards'
-
UN rights council launches probe into violations in Afghanistan
-
UK author Jilly Cooper dies aged 88
-
Jilly Cooper: Britain's queen of the 'bonkbuster' novel
-
Streaming stars' Le Mans race scores Twitch viewer record
-
England rugby star Moody 'shocked' by motor neurone disease diagnosis
-
Leopard captured after wandering into Indonesian hotel
-
Israel, Hamas due in Egypt for ceasefire talks
-
Rescuers scramble to deliver aid after deadly Nepal, India floods
-
Tokyo stocks soar on Takaichi win, Paris sinks as French PM resigns
-
OpenAI offers more copyright control for Sora 2 videos
-
Australia prosecutors appeal 'inadequate' sentence for mushroom murderer: media
-
Rugby World Cup-winning England star Moody has motor neurone disease
-
Trump says White House to host UFC fight on his 80th birthday
-
Vast reserves, but little to drink: Tajikistan's water struggles
-
US government shutdown may last weeks, analysts warn
-
Arsenal host Lyon to start new Women's Champions League format
-
Gloves off, Red run, vested interests: Singapore GP talking points
-
Bills, Eagles lose unbeaten records in day of upsets
-
Muller on target as Vancouver thrash San Jose to go joint top
-
Tokyo soars, yen sinks after Takaichi win on mixed day for Asia
-
China's chip challenge: the race to match US tech
-
UN rights council to decide on creating Afghanistan probe
-
Indonesia sense World Cup chance as Asian qualifying reaches climax
-
ICC to give war crimes verdict on Sudan militia chief
-
Matthieu Blazy to step out as Coco's heir in Chanel debut
-
Only man to appeal in Gisele Pelicot case says not a 'rapist'
-
Appetite-regulating hormones in focus as first Nobel Prizes fall
-
Gisele Pelicot: French rape survivor and global icon
-
Negotiators due in Egypt for Gaza talks as Trump urges quick action
-
'My heart sank': Surging scams roil US job hunters
-
Competition heats up to challenge Nvidia's AI chip dominance
-
UK police to get greater powers to restrict demos
-
Global Tech Pioneers CZ and Co-Founder of Shazam to Headline FinTech Forward 2025 in Bahrain
-
Guerrero grand slam fuels Blue Jays in 13-7 rout of Yankees
-
Five-try Bayonne stun champions Toulouse to go top in France
-
Fisk reels in Higgo to win maiden PGA Tour title in Mississippi
-
Aces overpower Mercury for 2-0 lead in WNBA Finals
NGG | -0.03% | 73.41 | $ | |
SCS | -0.44% | 17.035 | $ | |
BCC | -1.5% | 76.48 | $ | |
JRI | -0.46% | 14.235 | $ | |
GSK | 1.06% | 43.815 | $ | |
RELX | 0.26% | 46.53 | $ | |
RIO | 1.68% | 67.24 | $ | |
CMSD | -0.58% | 24.31 | $ | |
BCE | -0.91% | 23.15 | $ | |
RYCEF | -0.06% | 15.75 | $ | |
BTI | -0.45% | 51.01 | $ | |
BP | 2.46% | 35.02 | $ | |
AZN | 0.86% | 86.05 | $ | |
VOD | -0.49% | 11.305 | $ | |
RBGPF | -2.92% | 76 | $ | |
CMSC | -0.32% | 23.795 | $ |

How Biden cancer diagnosis could have gone undetected
Joe Biden's diagnosis with an aggressive form of prostate cancer has spurred some prominent conservatives to accuse the former president of a cover-up, but oncologists told AFP that screening limitations could very well have left his condition undetected until now.
The 82-year-old received the diagnosis last week after he experienced urinary issues and a prostate nodule was found, his office said Sunday.
While President Donald Trump said he was "saddened" to learn of his rival's condition, a chorus of Republicans led by Vice President JD Vance and Donald Trump Jr said or shared conspiratorial posts to the effect that Biden and his White House medical team had long concealed his illness for political purposes.
Questions over Biden's health dogged him throughout the waning months of his presidency and his short-lived reelection campaign. And they have been renewed in recent weeks ahead of the expected release of a book detailing what it calls his declining physical condition.
Prostate cancer, the most common among men, is typically diagnosed much sooner than other kinds of cancer. It can be caught in its early stages using blood tests that measure for a protein called PSA.
Medical experts interviewed by AFP said the late identification of an advanced cancer would not be unheard of, even for a former president receiving top-of-the-line medical care.
"We can't rule out the possibility that it was an aggressive form that developed quickly," said Natacha Naoun, an oncologist with France's Gustave-Roussy Institute.
Annual PSA screening after the age of 70 is not universally recommended.
The US Preventive Services Task Force advises against it, reasoning that the risk of false positives and the harms from biopsies and treatment outweigh the benefits.
"It could be they decided to stop checking PSA annually, and then he had urinary symptoms," said Russell Pachynski, an oncologist with Washington University in St. Louis, Missouri, who told AFP that prostate cancer patients do not always experience telltale pains or signs.
It is also possible that Biden was undergoing routine screenings, but that those checks failed to turn up indications of cancer, Pachynski said.
"Maybe it was just unlucky that his particular cancer didn't express a lot of PSA and he still had a normal PSA. In that setting, you would not go checking the prostate or do a biopsy, etcetera, unless it was driven by symptoms."
Otis Brawley, an oncologist and epidemiologist at Johns Hopkins University, said studies have shown both PSA testing and rectal exams are imperfect.
"It is not unusual for a man to be diagnosed with metastatic prostate disease despite normal annual screening," he told AFP. "This is part of the limitations of prostate screening."
T.Germann--VB